Related Experiment Videos
Amniotic fluid embolism
1Lake Norman Regional Medical Center, 171 Fairview Road, PO Box 3250, Mooresville, NC 28117, USA. Pamela.rudisill@lnrmc.hma-corp.com
Critical Care Nursing Clinics of North America
|May 18, 2004
Summary
Amniotic fluid embolism (AFE), a rare but severe pregnancy complication, can occur during or after childbirth. This condition affects women globally, with varying reported incidence rates.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
Background:
- Amniotic fluid embolism (AFE), also known as anaphylactoid syndrome of pregnancy, is a rare and often fatal condition.
- It is a leading cause of maternal mortality worldwide.
Purpose of the Study:
- To describe the incidence and global prevalence of amniotic fluid embolism.
- To highlight the catastrophic nature of AFE during pregnancy and postpartum.
Main Methods:
- Literature review of global incidence data.
- Analysis of AFE occurrence in developed and undeveloped countries.
Main Results:
- AFE occurs globally, affecting both developed and undeveloped regions.
- Incidence rates vary, ranging from 1 in 80,000 live births worldwide.
- In the United States, AFE incidence is reported between 1 in 20,000 to 80,000 deliveries.
Conclusions:
- Amniotic fluid embolism is a rare but significant obstetric emergency.
- Continued surveillance and research are crucial for understanding and managing AFE.